According to Fact.MR, the medical membranes industry was valued at $2 billion in 2020 and is projected to surpass $3 billion by 2031, with a robust CAGR of 7%. Ultrafiltration membrane sales are expected to reach $1 billion by 2031, growing at a CAGR of 7%, while microfiltration membrane sales are forecasted to expand at a 6% CAGR during the same period.
Medical membrane technology is vital for a range of medical applications, especially in critical treatments. Key uses include drug delivery, tissue regeneration, artificial organs, and diagnostic devices, such as bio-separations and medical device coatings.
Download a Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=6661
What Challenges Are Medical Membrane Suppliers Facing?
Although medical membranes are crafted from medical-grade polymers, they must undergo an extensive in-process validation phase lasting 3–6 months to receive certification. Once the membrane or its components are validated, the device incorporating the membrane must also go through a separate certification process.
Despite the growing demand for medical products and devices, manufacturers face significant regulatory hurdles due to the stringent, multi-layered regulations imposed by the FDA.
Additionally, the operational lifespan of membranes used in medical separation processes is limited, requiring regular replacement. Membranes used in various procedures are also susceptible to fouling, which compromises their performance and operational efficiency.
In applications like pharmaceutical water treatment or filtration and purification processes, unwanted substances such as iron, manganese, calcium, sulfate, and other ions can form deposits on the membrane's surface, leading to damage and diminished membrane properties.
As a result, the lengthy validation processes and high maintenance costs of medical membranes act as significant barriers to market growth
Country-Wise Analysis
The U.S. medical membranes market is set to reach $735 million by 2021, while China is projected to hit $350 million by 2031, growing at a robust 9% CAGR. Japan and Canada are expected to grow at 4% and 6% CAGRs, respectively, over the next decade. In Europe, Germany’s market will expand at 7% CAGR, with the rest of Europe reaching $386 million by 2031.
Key drivers include the rising demand for high-purity products, growing disease prevalence, and advancements in healthcare and life sciences. Applications such as haemodialysis, pharmaceutical filtration, venting, gas filtration, and sterile filtration further fuel growth.
The increasing number of ESRD patients needing dialysis is a major factor, boosting global demand for efficient blood purification and filtration solutions.
Competitive Landscape
Key players are expanding facilities and acquiring businesses to strengthen market positions.
- 3M (2017): Invested $40M to expand dialysis membrane production, boosting market reach.
- Merck Millipore (2017): Acquired Natrix Separation (Canada) to enhance its product portfolio and presence in North America.
- Asahi Kasei (2017): Began building a new plant for cellulose hollow fiber membranes for Planova virus filters.
- Sartorius (2016): Launched a PES membrane for its Sartocon benchtop filtration systems.
Comments
0 comment